ArticleACS medicinal chemistry letters2019

Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode.

Jun Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.